[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-362269-105":59,"doc-detail-362269-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","albumin-nanoparticles-as-multifunctional-carriers-for-advanced-therapeutics-abstract","Albumin Nanoparticles as Multifunctional Carriers for Advanced Therapeutics - Abstract","","Modern medicine requires effective, continuous, and safe therapies, largely determined by targeted drug delivery and sustained activity at disease sites. This work describes albumin nanoparticles as drug-delivery platforms designed to improve pharmacokinetics and enhance transport to affected tissues. Examples such as Abraxane, Optison, and Nanocoll illustrate albumin-based carrier potential. The article surveys advances in albumin nanoparticles for delivery, targeting, and imaging, and outlines synthesis and surface modification strategies. It also discusses multimodal theranostic platforms, emphasizing albumin’s promise to improve cancer therapy.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/albumin-nanoparticles-as-multifunctional-carriers-for-advanced-therapeutics-abstract/362269/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/albumin-nanoparticles-as-multifunctional-carriers-for-advanced-therapeutics-abstract/362269.png","ImageObject",300,407,{"name":92,"@type":93},"Aurelia","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-29","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":14},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"Why are albumin-based nanoparticles considered attractive drug carriers?","Question",{"text":112,"@type":113},"They offer favourable pharmacokinetics, high drug delivery efficiency, low cytotoxicity, facile incorporation of therapeutic agents, and functional groups that enable simple surface modification.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"What surface modification strategies are highlighted for albumin nanoparticles?",{"text":117,"@type":113},"Key approaches include folic acid, polymers, monoclonal antibodies, apolipoprotein, polyethylene glycol (PEG), and peptides to enhance uptake, targeting, circulation time, and penetration.",{"name":119,"@type":110,"acceptedAnswer":120},"How do albumin nanoparticles support theranostics in cancer therapy?",{"text":121,"@type":113},"Theranostic platforms combine tumour-localising elements with drug targeting and activation mechanisms after the payload reaches the target tissue, enabling coordinated imaging and treatment using albumin-based systems.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},362269,1792166866,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":14,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":56,"language":139,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":67,"update_tm":143,"read_time":144,"preview_page_count":19,"preview_urls":145},1099514068365,"https://ap-avatar.wpscdn.com/avatar/10000253d8d9f28188e?x-image-process=image/resize,m_fixed,w_180,h_180&k=1794309523707217728","Review  \nAlbumin Nanoparticles as Multifunctional Carriers for Advanced Therapeutics  \nBogusława Konopska 1, *, Janusz Sokołowski 2, Anna Wo´zniak 3, Mikołaj Kondracki 4, Jakub Federowicz 4, Wojciech Grodzki 4,5, Agnieszka Bronowicka-Szydełko 5,† and Katarzyna Madziarska 3,†  \nAcademic Editors: Diana Savu and Roxana Cristina Popescu  \nReceived: 26 November 2025  \nRevised: 15 January 2026  \nAccepted: 16 January 2026  \nPublished: 20 January 2026  \nCopyright: © 2026 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license.  \n1 Department of Laboratory Diagnostics, Faculty of Pharmacy, Wroclaw Medical University, 50-556 Wroclaw, Poland  \n2 Department of Emergency Medicine, Faculty of Medicine, Wroclaw Medical University, 50-556 Wroclaw, Poland; [janusz.sokolowski@umw.edu.pl](janusz.sokolowski@umw.edu.pl)  \n3 Clinical Department of Diabetology, Hypertension and Internal Diseases, Faculty of Medicine, Wroclaw Medical University, 50-556 Wroclaw, Poland; [anna.wozniak@umw.edu.pl](anna.wozniak@umw.edu.pl) (A.W.); [katarzyna.madziarska@umw.edu.pl](katarzyna.madziarska@umw.edu.pl) (K.M.)  \n4 Faculty of Medicine, Wroclaw Medical University, 50-367 Wroclaw, Poland; [mikolaj.kondracki@student.umw.edu.pl](mikolaj.kondracki@student.umw.edu.pl) (M.K.)  \n5 Department of Biochemistry and Immunochemistry, Faculty of Medicine, Wroclaw Medical University, 50-369 Wroclaw, Poland; [agnieszka.bronowicka-szydelko@umw.edu.pl](agnieszka.bronowicka-szydelko@umw.edu.pl)  \n* [Correspondence: boguslawa.konopska@umw.edu.pl](Correspondence: boguslawa.konopska@umw.edu.pl); Tel.: +48-717840167 † These authors contributed equally to this work.  \nAbstract  \nModern medicine requires effective, continuous, and safe therapies, which largely depend on the targeted delivery and activity of the drug. This goal can be achieved by designing drug delivery systems with improved pharmacokinetic properties and enhanced drug transport to the affected tissue. Human serum albumin (HSA) is an attractive carrier for the synthesis of therapeutic nanoparticles, several of which have already been approved by the United States Food and Drug Administration (FDA) . The success of Abraxane as an effective treatment for metastatic breast cancer and non-small cell lung carcinoma, the application of Optison in ultrasound imaging, and the use of Nanocoll as an agent for SPECT diagnosticsin sentinel node localisation confirm the strong potential of albumin-based systems. Further benefits are expected inpatients with soft tissue cancers, as LadRx is seeking FDA marketing approval for Aldoxorubicin. The future of oncology lies in theranostics, which combines a tumour-localising factor on one platform with a drug targeting cancer cells and a factor that activates the cytotoxicity of the drug after it reaches the target tissue. This article presents recent advancements in albumin-based nanoparticles for drug delivery, targeting, and imaging. It also briefly discusses methods of synthesis and surface modification of albumin nanocarriers to enable targeted delivery to pathological sites. Finally, it outlines the latest approaches in multimodal theranostic platforms, highlighting albumin’s potential to improve cancer therapy.  \nKeywords: albumin; drug delivery systems; nanoparticles; theranostics  \n1. Introduction  \nAlbumins are widely used in the synthesis of nanocarriers for medical applications. Their popularity arises from their broad availability, low production cost, biodegradability, and non-immunogenicity [1,2] . Albumin-based drug delivery nanosystems combine the intrinsic advantages of albumin as a carrier with the unique benefits of nanoparticles. They  \nPharmaceutics 2026, 18, 130 [https://doi.org/10.3390/pharmaceutics18010130](https://doi.org/10.3390/pharmaceutics18010130)  \nare characterised by favourable pharmacokinetics, high drug delivery efficiency, and lo","cbCaijtxtOOyWTZY","https://ap.wps.com/l/cbCaijtxtOOyWTZY","pdf",827415,"English","# Abstract\n# Keywords\n# 1. Introduction\n## Albumin-based nanocarrier properties\n## Surface modification strategies\n## Biomedical applications and cancer focus","[{\"question\":\"Why are albumin-based nanoparticles considered attractive drug carriers?\",\"answer\":\"They offer favourable pharmacokinetics, high drug delivery efficiency, low cytotoxicity, facile incorporation of therapeutic agents, and functional groups that enable simple surface modification.\"},{\"question\":\"What surface modification strategies are highlighted for albumin nanoparticles?\",\"answer\":\"Key approaches include folic acid, polymers, monoclonal antibodies, apolipoprotein, polyethylene glycol (PEG), and peptides to enhance uptake, targeting, circulation time, and penetration.\"},{\"question\":\"How do albumin nanoparticles support theranostics in cancer therapy?\",\"answer\":\"Theranostic platforms combine tumour-localising elements with drug targeting and activation mechanisms after the payload reaches the target tissue, enabling coordinated imaging and treatment using albumin-based systems.\"}]","Albumin Nanoparticles as Multifunctional Carriers for Advanced Therapeutics - Abstract | PDF",1790146925,48,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/8c8833f2d2fb79fbe403f87c791a0643.webp",983,1390,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f66c7e3bfc532ba661d51dadc672af2e.webp",982,1388,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/904e29715af269d2b07eb5f7fffdf4c0.webp",981,1387,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/73291175a448a21f22f8b05169f2d752.webp",980,1385]